Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fiorella Murillo Perez

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|October 30, 2025
Treatment Persistence, Normal Alkaline Phosphatase and Clinical Outcomes in Primary Biliary CholangitisKris V Kowdley, Jonathan Ieyoub, Yi Pan, et al.
Journal of Medical Economics|December 9, 2025
Association between elevations in alkaline phosphatase and healthcare utilization and costs among individuals with primary biliary cholangitis in the United StatesRobert G Gish, Michel H Mendler, Edward A Mena, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 23, 2025
Assessment of PBC Pruritus From the ITCH-E Study: Quality of Life, Productivity, and Treatment ExperiencesCynthia Levy, Zobair M Younossi, Marlyn J Mayo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survivalC Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, et al.
Gastroenterology|September 23, 2022
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External ControlsC Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|October 30, 2025
Treatment Persistence, Normal Alkaline Phosphatase and Clinical Outcomes in Primary Biliary CholangitisKris V Kowdley, Jonathan Ieyoub, Yi Pan, et al.
Journal of Medical Economics|December 9, 2025
Association between elevations in alkaline phosphatase and healthcare utilization and costs among individuals with primary biliary cholangitis in the United StatesRobert G Gish, Michel H Mendler, Edward A Mena, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 23, 2025
Assessment of PBC Pruritus From the ITCH-E Study: Quality of Life, Productivity, and Treatment ExperiencesCynthia Levy, Zobair M Younossi, Marlyn J Mayo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survivalC Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, et al.
Gastroenterology|September 23, 2022
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External ControlsC Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, et al.
Pageof 1